Does TOFACITINIB Cause White blood cell count increased? 403 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 403 reports of White blood cell count increased have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.3% of all adverse event reports for TOFACITINIB.
403
Reports of White blood cell count increased with TOFACITINIB
0.3%
of all TOFACITINIB reports
114
Deaths
194
Hospitalizations
How Dangerous Is White blood cell count increased From TOFACITINIB?
Of the 403 reports, 114 (28.3%) resulted in death, 194 (48.1%) required hospitalization, and 122 (30.3%) were considered life-threatening.
Is White blood cell count increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 403 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause White blood cell count increased?
CLOZAPINE (2,988)
ADALIMUMAB (1,710)
RUXOLITINIB (1,529)
IBRUTINIB (1,390)
RITUXIMAB (886)
METHOTREXATE (741)
PREDNISONE (716)
ETANERCEPT (615)
IMATINIB (520)
TOCILIZUMAB (478)
Which TOFACITINIB Alternatives Have Lower White blood cell count increased Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN